These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 28270510

  • 1. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N, Nakayama Y, Yamaguchi N.
    J Biol Chem; 2017 May 19; 292(20):8136-8148. PubMed ID: 28270510
    [Abstract] [Full Text] [Related]

  • 2. Delineation of a FOXA1/ERα/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer.
    Wright TM, Wardell SE, Jasper JS, Stice JP, Safi R, Nelson ER, McDonnell DP.
    Mol Cancer Res; 2014 Dec 19; 12(12):1829-39. PubMed ID: 25100862
    [Abstract] [Full Text] [Related]

  • 3. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
    Fu X, Jeselsohn R, Pereira R, Hollingsworth EF, Creighton CJ, Li F, Shea M, Nardone A, De Angelis C, Heiser LM, Anur P, Wang N, Grasso CS, Spellman PT, Griffith OL, Tsimelzon A, Gutierrez C, Huang S, Edwards DP, Trivedi MV, Rimawi MF, Lopez-Terrada D, Hilsenbeck SG, Gray JW, Brown M, Osborne CK, Schiff R.
    Proc Natl Acad Sci U S A; 2016 Oct 25; 113(43):E6600-E6609. PubMed ID: 27791031
    [Abstract] [Full Text] [Related]

  • 4. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.
    Droog M, Nevedomskaya E, Kim Y, Severson T, Flach KD, Opdam M, Schuurman K, Gradowska P, Hauptmann M, Dackus G, Hollema H, Mourits M, Nederlof P, van Boven H, Linn SC, Wessels L, van Leeuwen FE, Zwart W.
    Cancer Res; 2016 Jul 01; 76(13):3773-84. PubMed ID: 27197147
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
    Zhang B, Zhang X, Tang B, Zheng P, Zhang Y.
    Breast Cancer Res Treat; 2012 Nov 01; 136(2):399-406. PubMed ID: 23053650
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
    Lee JY, Park YJ, Oh N, Kwack KB, Park KS.
    Oncotarget; 2017 Jun 27; 8(26):42752-42760. PubMed ID: 28514748
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W, Dong N, Wang P, Shi C, Yang J, Wang J.
    Cell Biol Toxicol; 2017 Apr 27; 33(2):183-195. PubMed ID: 27837347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.
    Tachi K, Shiraishi A, Bando H, Yamashita T, Tsuboi I, Kato T, Hara H, Ohneda O.
    Cancer Sci; 2016 Mar 27; 107(3):281-9. PubMed ID: 26708273
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.
    Moerkens M, Zhang Y, Wester L, van de Water B, Meerman JH.
    BMC Cancer; 2014 Apr 23; 14():283. PubMed ID: 24758408
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.
    Nathan S, Ma Y, Tomita YA, De Oliveira E, Brown ML, Rosen EM.
    Breast Cancer Res Treat; 2017 Dec 23; 166(3):681-693. PubMed ID: 28808806
    [Abstract] [Full Text] [Related]

  • 20. δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancer.
    Guo S, Li Y, Tong Q, Gu F, Zhu T, Fu L, Yang S.
    PLoS One; 2012 Dec 23; 7(12):e52380. PubMed ID: 23285017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.